Onconova Therapeutics Inc a Phase stage biopharmaceutical company discovering and developing novel products to treat cancer with a focus on myelodysplastic syndromes MDS today announced they have entered into a Distribution License and Supply Agreement with Knight Therapeutics Inc Knight a Canadianb...

Phenomics Health Inc a precision medicine company based on the bioinformatics platform today announced that it has acquired Precera Bioscience based in Franklin Tennessee USA Patented drug metabolome technology portfolio

Dragonfly Therapeutics Dragonfly a biotechnology company developing novel immunotherapies that harness the innate immune system to treat disease and AbbVie NYSE ABBV a researchbased global biopharmaceutical company today announced a multitarget research collaboration designed to advance a number of...

Astellas Pharma Inc and Welldoc Inc today announced that the companies have entered into a collaboration and license agreement directed toward the development and commercialization of digital health solutions Under the agreement Astellas and Welldoc will jointly develop and commercialize BlueStar in...

Personalis Inc a leader in advanced genomics for cancer today announced a collaboration with Merck KGaA Darmstadt Germany a leading science and technology company to investigate novel biomarkers of response and mechanisms of resistance to cancer therapies Merck KGaA Darmstadt Germany will utilize Pe...

Antares Pharma Inctoday announced that it has entered into a global agreement with Idorsia Pharmaceuticals Ltd Idorsia SIX IDIA to develop a novel drugdevice product combining selatogrel Idorsias potent fastacting and highly selective PY receptor antagonist under development with the Antares subcuta...

Alkermes plc and Rodin Therapeutics Inc Rodin today announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin a privately held biopharmaceutical company focused on developing novel small molecule therapeutics for synaptopathies This transaction builds on Al...

Dicerna Pharmaceuticals Inc and Novo Nordisk AS today announced an agreement to discover and develop novel therapies for the treatment of liverrelated cardiometabolic diseases using Dicernas proprietary GalXC RNAi platform technology The collaboration plans to explore more than liver cell targets a...

WuXi AppTec a leading global provider of RD and manufacturing services enabling companies in the pharmaceutical biotechnology and medical device industries today announced its Lab Testing Division LTD has expanded the Suzhou safety assessment facility by increasing toxicology capacity by to meet gl...

Glaukos Corporation an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma corneal disorders and retinal diseases today announced that it has completed its previously announced acquisition of Avedro Inc

ProQR Therapeutics NV a company dedicated to changing lives through the creation of transformative RNA medicines for severe genetic rare diseases today announced that it received Orphan Drug designation ODD from the Food and Drug Administration FDA for QR

MC Therapeutics an emerging pharmaceutical company focused on novel PAD Technologybased topical therapies for chronic inflammatory conditions today announced that the US Food and Drug Administration FDA has accepted for review the New Drug Application NDA for Wynzora Cream

Kiniksa Pharmaceuticals Ltd a biopharmaceutical company focused on discovering acquiring developing and commercializing therapeutic medicines for patients with significant unmet medical need today announced that the US Food and Drug Administration FDA granted Breakthrough Therapy designation for ril...

Alnylam Pharmaceuticals Inc the leading RNAi therapeutics company announced today that the US Food and Drug Administration FDA approved GIVLAARI givosiran injection for subcutaneous use for the treatment of adults with acute hepatic porphyria AHP

Sangamo Therapeutics Inc a genomic medicine company announced today that the United Kingdoms UK Medicines Healthcare Products Regulatory Agency MHRA has granted authorization of the firstinhuman clinical trial to evaluate a Chimeric Antigen Receptor Regulatory T Cell CARTreg therapy

Newron Pharmaceuticals SpA a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system announced today that the US Food and Drug Administration FDA has granted the Rare Pediatric Disease designation for sarizotan t...

The South East Asia region presents a diverse range of opportunities for multinational pharmaceutical firms During the emerging Asian region is experiencing key progress with respect to healthcare reforms shaping opportunities for local and foreign drugmakers A few trends are expected to persist in...

Pfizer Inc today announced the United States US Food and Drug Administration FDA has approved ABRILADA adalimumabafzb as a biosimilar to Humira adalimumab for the treatment of certain patients with rheumatoid arthritis juvenile idiopathic arthritis psoriatic arthritis ankylosing spondylitis adult Cr...